EFFECT OF LOW-LEVEL INFRARED LASER ON P53 AGGREGATION IN BREAST CANCER CELLS

Vol 3, 2025 - 331447
Abstract
Favorite this paper
How to cite this paper?
Abstract

Photobiomodulation (PBM) is a non-invasive approach that promotes molecular, cellular, and systemic effects, such as enhanced ATP synthesis, cell proliferation, and tissue repair. In cancer, however, its use is controversial due to concerns that it may promote tumor cell proliferation. Breast cancer is the leading cause of cancer-related deaths among women worldwide, with p53 mutations playing a key role in tumor progression. The p53 protein is a tumor suppressor, involved in cell cycle arrest, DNA repair, and apoptosis. Mutations in this gene impair its function contributing to cancer development. Although PBM has been explored for reducing amyloidogenic proteins in neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, its impacts on protein aggregation in cancer is still unclear. Therefore, we evaluated whether low-power infrared laser irradiation (808 nm; 20 and 200 J/cm²) affects p53 aggregation in MDA-MB-231 breast cancer cells. To our knowledge, this is one of the first studies to explore the effect of PBM on protein aggregation in a cancer model. Cells were irradiated and incubated for 24 and 48 hours, with non-irradiated cells as controls. Protein aggregation was assessed by dot blot and western blot, while p53 localization was analyzed by immunofluorescence. Cell viability was measured by LDH release. Preliminary results suggest that infrared LLLT does not alter the quantity of p53 by dot blot and western blot assays, or modulate the nuclear aggregates localization of mutant p53 R280K at either fluence or time point. Additionally, no changes in cell viability were observed. Our findings demonstrate that low-level infrared laser irradiation (808 nm, 20 and 200 J/cm²) does not induce cytotoxic effects or modulate the expression or aggregation of mutant p53 in MDA-MB-231 breast cancer cells at 24- and 48-hours post-treatment. These results suggest that, under the tested conditions, a PBM does not affect mutant p53 behavior or compromise cell integrity, supporting its safety in breast cancer models harboring TP53 mutations. However, further studies using additional cell lines, functional assays, and in vivo models are needed to better understand the biological effects and therapeutic potential of photobiomodulation in oncology.

Share your ideas or questions with the authors!

Did you know that the greatest stimulus in scientific and cultural development is curiosity? Leave your questions or suggestions to the author!

Sign in to interact

Have a question or suggestion? Share your feedback with the authors!

Institutions
  • 1 Universidade Federal do Rio de Janeiro
  • 2 Universidade do Estado do Rio de Janeiro
Track
  • 5. Photobiology
Keywords
Breast cancer
Laser therapy
Protein aggregation
P53
photobiomodulation